<table border="1"><tr><th>Name (IUPAC) systematic</th><td><ul><li>IUPAC Name | N-(2-(4-(4-fluorobenzylcarbamoil)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide</li></ul></td></tr><tr><th>CAS number</th><td><ul><li>518048-05-0</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li> J05 | AX08</li></ul></td></tr><tr><th>ATCvet code</th><td><ul><li>Not awarded</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 20 | H | 21 | N | 6 | F | O | 5</li></ul></td></tr><tr><th>Weight mol.</th><td><ul><li>444.4163 g/mol</li></ul></td></tr><tr><th>Protein Union</th><td><ul><li>83%</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li> Hepatic (UGT1A1)</li></ul></td></tr><tr><th>Average life</th><td><ul><li>9 hours</li></ul></td></tr><tr><th>Excretion</th><td><ul><li>Fecal and renal</li></ul></td></tr><tr><th>Commercial name</th><td><ul><li> Isentress®, Isentress HD®</li></ul></td></tr><tr><th>Routes of adm.</th><td><ul><li> Oral use</li></ul></td></tr></table>